In a report released today, Gregory Renza from RBC Capital maintained a Buy rating on Perspective Therapeutics (CATX – Research Report). The company’s shares closed yesterday at $6.96. Don't Miss our ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Incyte (INCY – Research Report) yesterday and set a price target of $74.00. The ...

Fintel reports that on November 18, 2024, RBC Capital initiated coverage of TechnipFMC (NYSE:FTI) with a Outperform ...

Stock futures hovered near the flatline on Tuesday evening, as investors looked toward a key earnings report from tech giant ...

RBC Capital analyst Manjari Dhar initiated coverage of J Sainsbury (JSAIY) with an Outperform rating and 300 GBp price target ...

Tariffs have taken the spotlight as a policy issue as S&P 500 companies have discussed earnings with analysts since the U.S.

Rathbones Asset Management has expanded its multi-asset team with the hire of equity research analyst Emma Letheren.

RBC Capital raised its price target for Tesla (NASDAQ: TSLA) to $387 from $323 in a note Friday, citing growing confidence in ...

On Friday, CoStar Group Inc (CSGP) stock saw a decline, ending the day at $71.25 which represents a decrease of $-3.79 or -5.05% from the prior close of $75.04. The stock opened at $74.96 and touched ...

Investing.com - Microsoft's first-quarter results and its current-quarter guidance have left many disappointed investors in ...

How our approach to investing can inform your stock-picking process. We sell different types of products and services to both investment professionals and individual investors. These products and ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...